Dermatan sulfate

硫酸皮肤素

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameDermatan sulfate
Drug Alias NameChondroitin sulfate B硫酸软骨素BMistralMF-701MF-777
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProthrombin inhibitors
TargetsProthrombin
Therapy Area/IndicationsThrombocytopeniaThrombosisVenous Thromboembolism
Global Approved IndicationsThrombocytopeniaThrombosisVenous Thromboembolism
Approved Indications in ChinaN/A
Original Approved Country/TerritoryItaly
Original Approved Date1998/07/01
Country/TerritoryItaly
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesMediolanum Farmaceutici Spa
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsThrombocytopeniaThrombosisVenous Thromboembolism
Inactive IndicationsN/A

Other Information

ATC CodeB01AX04
Related LinksN/A